SPC waiver is facing ‘intimidation’ by US

Europe “will not capitulate” in the face of US intimidation over plans for a manufacturing waiver during the term of supplementary protection certificates (SPCs), according to European off-patent industry association Medicines for Europe.

Europe “will not capitulate” in the face of US intimidation over plans for a manufacturing waiver during the term of supplementary protection certificates (SPCs), according to European off-patent industry association Medicines for Europe.

At the end of October, Medicines for Europe pointed out, the US Department of Commerce – along with the US...

More from Regulation

More from Policy & Regulation